Friday, May 21, 2021 9:22:51 PM
Statistical analysis plan was signed before database lock in December. The statistical analysis, blinded to $CVM , was started then. Full data analysis because (first-in-human). Work of ICON gets double checked by another group. When done, final report and data announcement.
My interpretation:
The Statistical Analysis Plan included the double check by another group.
This was blinded to CVM, as the Statistical Analysis Plan is prepared by the CRO.
SAP Info
6. Roles and Responsibility – signatures
Item 6a: Signature of person writing the SAP
Explanation
The signature of the person writing the SAP is crucial as it identifies who is responsible for the SAP and
that they have approved the SAP. In all circumstances this should be signed and dated. If an update
has been made then the author of the update should sign the updated version.
Item 6b: Signature of senior statistician responsible
Explanation
The signature of the senior statistician responsible for overseeing the trial is important as it highlights
that the SAP has been reviewed and approved by an experienced statistician. In some circumstances
the senior statistician may be the person writing the SAP and such a dual role should be reflected in
the signatories. The signature should always be dated.
Item 6c: Signature of chief investigator/clinical lead
Explanation
The signature of the chief investigator/clinical lead demonstrates that they have reviewed and
approved the SAP. Once the final version has been approved and signed off it avoids any post-hoc
changes being made without the justification and approval of all signatory members to maintain
internal and external trial validity. The signature should always be dated.
But then again, I'm only the piano player.
Recent CVM News
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/04/2025 05:15:16 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:31:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2025 09:31:28 PM
- CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025 • Newsfile • 10/20/2025 01:00:00 PM
- CEL-SCI Corporation to Present at LD Micro "Main Event" Investor Conference • Newsfile • 10/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 08:01:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:57:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2025 07:46:01 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/29/2025 08:16:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2025 05:15:44 PM
- CEL-SCI Announces Closing of $10 Million Public Offering • Business Wire • 08/29/2025 04:52:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/28/2025 08:24:34 PM
